Sunshine Biopharma on the hunt for CMO partner

Sunshine Biopharma is eyeing a Phase I trial of its Adva-27a treatment for drug-resistant breast cancer, and the company is in talks to find a CMO partner to manufacture enough of the drug to get through IND-enabling animal toxicity studies and the planned trial. More

Suggested Articles

WuXi AppTec has cut the ribbon on its expanded Laboratory Testing Division in New Jersey as it looks to boost its integrated testing service portfolio.

St. Jude, Microsoft and DNAnexus have created a data-sharing and analysis platform to help accelerate pediatric cancer research.

The money will be used to expand its footprint in both China and the U.S., including a new R&D operation in Boston.